MDMA
Enable an agent to identify MDMA, assess the identity and condition of a particular sample, and determine which handling, testing, storage or transfer actions require further evidence or authorization.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to identify MDMA, assess the identity and condition of a particular sample, and determine which handling, testing, storage or transfer actions require further evidence or authorization.
MDMA (3,4-methylenedioxymethamphetamine) is a synthetic chiral substituted amphetamine, molecular formula C11H15NO2, whose psychoactive effects arise primarily from increased serotonin, norepinephrine and dopamine signalling.
It can be Reconcile a sample's claimed MDMA identity with analytical evidence and form-specific identifiers.; Compare content measurements after aligning salt basis, units, sampling assumptions and uncertainty.; Identify which additional analyses are needed to resolve stereochemistry, adulterants or uncertain chemical form.; Assess whether a sample remains within its documented specification using storage history and analytical results.; Retrieve applicable handling requirements and verify authorization before storage, testing, transfer or disposal..
Distinguishing features
Require analytical evidence consistent with the 3,4-methylenedioxy ring substitution and N-methylated amphetamine structure; a street name, logo or appearance does not establish MDMA identity.
Distinguish MDMA from MDA and related substances through an analytical method capable of resolving those identities.
Distinguish free-base MDMA from a specified salt by recording the counterion and the chemical basis used for identity, mass and concentration.
Distinguish an unspecified stereochemical composition, a racemic mixture and an enantiomerically enriched material using appropriate evidence.
Distinguish the presence of MDMA in a mixture from a claim that the sample consists predominantly of MDMA or meets a stated purity specification.
Scope
+ Molecular identity of 3,4-methylenedioxymethamphetamine, including stereochemistry and form-specific identifiers
+ Free-base and salt forms, with counterion, hydration and reporting basis recorded explicitly
+ Sample identity, MDMA content, purity, impurities, adulterants and analytical uncertainty
+ Physical properties and stability tied to chemical form and measurement conditions
+ Substance-specific biological hazards and evidence relevant to exposure assessment
+ Regulatory identity and documented permissions for a specified jurisdiction and activity
- Tablets, capsules or other formulated products as complete products
- Manufacturing routes, precursor procurement and synthesis procedures
- Individual exposure events, diagnoses and clinical treatment decisions
- Psychotherapy protocols and clinical-trial operations
- Distribution networks, markets and recreational-use practices
Characteristics
- Chemical identity and identifier agreement
- Verified chemical name and structure; CAS, PubChem CID and EC identifiers where applicable, each associated with its chemical form Prevents identifiers for different salts, stereochemical forms or related compounds from being treated as interchangeable.
- Chemical form
- Free base; identified salt with counterion and stoichiometry; unresolved form Physical properties and quantitative reporting depend on which form is present.
- Stereochemical composition
- Enantiomer ratio or enantiomeric excess in %, with method; unspecified when unmeasured A non-chiral identity result does not establish the relative amounts of the enantiomers.
- MDMA content
- Mass fraction %, mg/g or mg/mL, with free-base or salt basis, uncertainty and sampling basis Makes results comparable without confusing salt mass, mixture mass and MDMA-equivalent content.
- Impurity and adulterant profile
- Identified substances and concentrations, plus unknown signals and method-specific detection limits A positive MDMA identification leaves other constituents and their hazards unresolved.
- Physical and thermal properties
- Phase at stated temperature and pressure; melting or decomposition behavior in °C; solubility in g/L for a stated solvent and temperature Supports form-specific identification and handling without importing constants from a different material.
- Sample condition
- Within specification; changed from baseline; degraded; insufficient evidence Connects storage history and repeat analysis to the sample's current suitability.
- Hazard evidence
- Links to form-specific safety documentation, toxicology evidence and applicable hazard classifications Separates established substance hazards from uncertain hazards introduced by sample composition.
- Activity-specific regulatory status
- Jurisdiction, effective date, controlled-substance entry, covered forms, proposed activity and authorization record A substance classification alone does not establish whether a particular actor may perform a particular action.
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 19 findings · 31 questions.
MDMA chemical identity Establishes which molecular, stereochemical and salt identity a claim of MDMA denotes.
MDMA identification must distinguish related compounds while preserving the registry's single substance entry.
Molecular discrimination
Separates MDMA from structurally related substances and unsupported product labels.
Structure-supported identity
Record whether evidence establishes the MDMA structure and discriminates relevant alternative identities.
- What structural definition and authoritative identifier records establish the intended MDMA identity? definition
- Which analytical evidence distinguishes this sample from MDA, related analogues and positional isomers? measurement
Form and stereochemistry
Qualifies molecular identity by salt form and enantiomeric composition.
Qualified MDMA form
Record free-base or salt identity separately from the evidence for stereochemical composition.
- Is the material free-base MDMA or a specified salt, and what establishes its counterion, stoichiometry and hydration state? definition
- Has enantiomeric composition been measured, and can the method support a racemic or enantiomerically enriched designation? measurement
MDMA sample composition Connects a substance identity to the measured composition of a particular sample.
Detecting MDMA does not establish its quantity, purity or the absence of other substances.
Content and reporting basis
Makes quantitative MDMA results interpretable across salts, mixtures and analytical methods.
Comparable MDMA content
Record assay values with the chemical and sample basis needed to compare them.
- What MDMA content was measured, with which units, uncertainty and free-base or specified-salt basis? measurement
- Does the result describe the sampled portion, a dry material, a solution or a demonstrably representative batch? boundary
Co-constituents and confidence
Records other detected substances and the limits of the analytical examination.
Bounded composition claim
Distinguish measured impurities and adulterants from constituents that were untested or unresolved.
- Which impurities, adulterants, residual solvents or unknown signals were found, and at what concentrations or detection limits? measurement
- Which laboratory report, sampling record and reference materials support the composition claim? provenance
- Which potential co-constituents fall outside the analytical method's coverage? boundary
MDMA physical state and stability Relates observed properties and storage history to the specified MDMA form.
Properties attributed simply to MDMA can obscure differences between free base, salts and mixed samples.
Form-specific properties
Associates physical constants with the material and conditions actually studied.
Conditioned property record
Record phase, thermal behavior and solubility only with a defined form and measurement context.
- What phase, melting or decomposition behavior and solubility are supported for this exact MDMA form under stated conditions? measurement
- Does each cited property concern the free base, a particular salt or a mixture, and is a reported boiling point experimentally established? boundary
Storage and condition change
Tracks whether environmental exposure has changed a sample's documented condition.
Evidenced sample stability
Connect storage conditions, packaging and analytical changes to supported stability claims.
- What temperature, light, moisture and container history is documented for this sample? provenance
- What evidence supports its current storage limits, retest interval or need for reassessment? action
MDMA biological hazards Organizes evidence about MDMA's biological activity and the hazards relevant to a sample.
An agent must distinguish MDMA-specific hazards, mixture hazards and claims that require individual clinical assessment.
Pharmacological evidence
Records the evidence and limits behind descriptions of MDMA's biological activity.
Bounded activity claims
Associate pharmacological claims with the studied substance, experimental setting and uncertainty.
- Which primary evidence supports claims about MDMA's monoamine-related activity, and which form or enantiomeric composition was studied? provenance
- Which conclusions concern laboratory mechanisms, human effects or a particular formulation, and where does extrapolation remain unresolved? boundary
Exposure and handling hazards
Connects toxicological evidence and sample composition to appropriate handling assessments.
Sample-relevant hazard assessment
Record applicable hazard evidence without treating an MDMA assay as proof of safety.
- What evidence addresses hyperthermia, hyponatremia, cardiovascular effects and serotonin toxicity, and under what exposure conditions? provenance
- Which hazards arise from MDMA itself, identified co-constituents or unresolved sample composition? boundary
- Which handling controls follow from the applicable safety documentation, and are authoritative occupational exposure limits available? action
MDMA regulatory control Determines how a specified MDMA identity and proposed activity relate to current legal controls.
MDMA permissions depend on jurisdiction, covered chemical forms, actor and activity rather than a universal legal label.
Jurisdictional substance coverage
Maps the material's identity to the relevant legal entry and its scope.
Dated control mapping
Record the authoritative control text and whether it covers the specific form or mixture.
- Which authoritative legal entry governs MDMA in the relevant jurisdiction on the decision date? provenance
- How does that entry address salts, stereoisomers, preparations and mixtures containing MDMA? boundary
Authorized custody and actions
Relates proposed handling to documented permissions and custody requirements.
Activity-specific permission
Establish whether the responsible actor has the permissions required for the proposed action.
- What current authorization covers this actor's proposed possession, analysis, transfer, import, export or disposal of MDMA? action
- Which custody, inventory, recipient-verification and disposal records must accompany that action? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- This is recalled knowledge, without consulted sources; verify identifiers before publication.
- Verify current jurisdiction-specific scheduling and therapeutic access before describing legal or clinical availability.
- Physical constants and hazard classifications require the specific salt, stereochemical composition, purity and measurement conditions; none are supplied here.
- Which of these check these first hold for the sense of MDMA this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Racemic MDMA
- (R)-MDMA
- (S)-MDMA
- MDMA free base
- MDMA hydrochloride
- Which of these kinds and varieties hold for the sense of MDMA this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- CAS Registry Number - 42542-10-9 - MDMA free base; the hydrochloride salt has a separate identifier.
- CAS Registry Number - 64057-70-1 - MDMA hydrochloride.
- PubChem CID - 1615 - MDMA compound record.
- Which of these identifiers and schemes hold for the sense of MDMA this model covers, and on what evidence? provenance
Standards and regulation
Recalled without web access and unsourced; every item is a lead to verify.
- United Nations Convention on Psychotropic Substances of 1971: MDMA is listed in Schedule I; national implementation and research permissions differ.
- Which of these standards and regulation hold for the sense of MDMA this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Nonmedical use for entactogenic effects, including feelings of emotional closeness, and stimulant effects.
- Investigational use alongside psychotherapy, particularly in research on post-traumatic stress disorder.
- Laboratory research on monoamine transporters and psychoactive drug effects.
- Analytical reference material for forensic and toxicological testing.
- Which of these real-world use hold for the sense of MDMA this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Molar mass of free base - 193.24 - g/mol
- Molar mass of anhydrous hydrochloride salt - 229.70 - g/mol
- Which of these typical measurements hold for the sense of MDMA this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Hyperthermia, potentially progressing to muscle breakdown and organ injury.
- Hyponatraemia associated with impaired water excretion and excessive water intake.
- Serotonin toxicity, especially with interacting serotonergic substances.
- Cardiovascular stress, including increased heart rate and blood pressure.
- Products sold as ecstasy or molly may have variable MDMA content or contain other substances.
- Which of these failure modes and hazards hold for the sense of MDMA this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- National laws differ in possession penalties, research licensing and permitted medical access.
- Street names and product presentation vary geographically and do not establish chemical identity or purity.
- Which of these regional variation hold for the sense of MDMA this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- MDA - MDA lacks the N-methyl group present in MDMA and is a distinct psychoactive compound.
- Methamphetamine - Methamphetamine lacks MDMA's 3,4-methylenedioxy ring substitution.
- Ecstasy - Ecstasy is a market name for drug products, often tablets; it does not guarantee that their contents are MDMA.
- MDMA hydrochloride - This is a salt form of MDMA with different formula mass and physical properties from the free base.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of MDMA this model covers, and on what evidence? provenance
What the second pass must settle
- Does an existing Vercy world model already cover MDMA and require this registry entry to link to it instead of receiving a separate publication?
- Which authoritative identifiers apply separately to free-base MDMA, its relevant salts and stereochemical forms?
- Which measured physical constants and stability limits are reliable for each form, particularly where reported thermal values may describe decomposition?
- Which analytical methods and sampling evidence are sufficient for the intended decisions about identity, MDMA content, stereochemistry and co-constituents?
- Which current jurisdiction-specific controls, hazard classifications and occupational exposure guidance apply to the intended setting?